top of page

What next when Antidepressants Don't Work

  • Writer: Sophroneo Psychiatry
    Sophroneo Psychiatry
  • Feb 9
  • 6 min read

An informational infographic titled "What Next When Antidepressants Don't Work." The image is split into two sections. The left side, labeled "Frustration & 'Not Working'," features a silhouette of a person looking out a rainy window next to a stack of pill bottles and a calendar marked "6-8 weeks... Still Waiting." A compass in the center points to the right side, labeled "Next Steps & New Options," which displays icons representing three pathways: Therapy Adjustments, Medication Strategies (Switch/Augment), and Advanced Treatments (featuring icons for TMS magnets and Spravato nasal spray), along with Care Level Changes.

Starting treatment for depression takes courage. You schedule the appointment, you pick up the prescription, you go to therapy and you wait. But what happens when weeks or months go by, and the heavy fog hasn’t lifted?

It is frustrating and disheartening, but it is also not uncommon. If you feel like your treatment has stalled, you haven't "failed." It may simply mean you need a different tool. This guide walks you through the next steps for treatment-resistant depression options, from troubleshooting your current plan to exploring advanced therapies like TMS.



What “not working” can mean in depression treatment

"Not working" can look different for everyone. Clinicians often categorize it into three buckets to decide the next move.

No response vs. partial response vs. relapse

  • No Response: You have taken the medication consistently for 6–8 weeks and feel absolutely no change in your mood or energy.

  • Partial Response: You feel somewhat better (e.g., you are sleeping better or crying less), but you still feel numb, low, or unable to enjoy life. This is often described as "feeling blunted."

  • Relapse (or "Poop-out"): The medication worked well for a while, but the symptoms have crept back in despite no change in your dose.

Side effects that prevent a fair trial

Sometimes a treatment could work biologically, but the side effects (nausea, insomnia, weight gain) make it impossible to stay on it long enough to find out. This counts as a failed trial—you cannot benefit from a medicine you cannot tolerate.


What to review before declaring "treatment-resistant depression"

Before jumping to a new diagnosis, it helps to review the basics. "Treatment-Resistant Depression" (TRD) generally means you haven't responded to at least two different antidepressants. But sometimes, other factors are at play.

Adherence and consistency

Are you taking the medication at the same time every day? Missing doses frequently can cause "mini-withdrawals" that mimic depression symptoms, making it hard to tell if the drug is working.

Dose and duration conversations

Did you take the medication for a full 6–8 weeks? Did you reach a therapeutic dose? Sometimes, a "failed" trial was simply too short or the dose was too low to be effective for your specific metabolism.

Sleep, substances, and medical factors

Alcohol and certain recreational substances are depressants. They can counteract the benefits of an antidepressant, rendering it less effective. Similarly, untreated sleep apnea or thyroid issues can keep energy low regardless of your mood medication.

Need a fresh look at your history? A comprehensive re-evaluation can spot these hidden blockers.


Other hidden factors

  • Seasonal Patterns: If you only feel this "stuck" in January, you might need seasonal-specific support.

  • Grief: If a major loss is keeping you down, standard medication may not fully resolve the pain of bereavement.


Which next-step options clinicians commonly consider

If you have optimized the basics and still struggle, your clinician typically looks at three pathways.

1. Therapy adjustments

If "talk therapy" feels stalled, switching modalities can help.

  • CBT (Cognitive Behavioral Therapy): Focuses on changing concrete thought patterns.

  • Trauma-Informed Care: If past trauma is blocking progress, standard counseling may not reach the root.

2. Medication strategies

  • Switching: Moving to a medication in a completely different class (e.g., from an SSRI to an SNRI or NDRI).

  • Augmentation: Keeping your current antidepressant (if it helps a little) and adding a second medication (like a mood stabilizer or atypical antipsychotic) to boost its effect.

3. Care level changes

If weekly outpatient visits aren't enough, some patients benefit from Intensive Outpatient Programs (IOP) or structured day programs to provide more stability.


When do advanced treatments enter the conversation?

When standard oral medications and therapy haven't provided relief, medical guidelines suggest considering interventional treatments.

How TMS is generally positioned

NeuroStar TMS (Transcranial Magnetic Stimulation) is an FDA-cleared, non-drug treatment. It is typically considered when:

  • You have tried at least 2–4 antidepressants without adequate success.

  • You cannot tolerate the side effects of medications.

  • You want to avoid the systemic effects of adding more drugs.

How Spravato/ketamine discussions may come up

Spravato™ (esketamine) is a nasal spray treatment used for treatment-resistant depression. It works differently than standard antidepressants, targeting the glutamate system in the brain. It is usually administered under supervision in a certified clinic (like Sophroneo) for patients who need a different mechanism of action.



What to expect if you explore TMS

TMS uses magnetic pulses (similar to an MRI) to stimulate underactive areas of the brain involved in mood regulation.

Evaluation and candidacy basics

Not everyone is a candidate (e.g., if you have non-removable metal in your head or a history of seizures). A consultation involves mapping your treatment history and checking your insurance coverage.

Treatment schedule overview

TMS is not a "one-and-done" pill.

  • Standard Course: Typically involves 5 sessions per week for about 4–6 weeks.

  • Session Duration: Each session lasts about 19–37 minutes.

  • Downtime: There is typically no downtime. You can drive yourself to and from appointments and return to work immediately.

Common concerns

  • Sensation: Most patients describe it as a tapping sensation on the scalp, not pain.

  • Side Effects: The most common side effect is temporary scalp discomfort or mild headache during the first week. It does not typically cause weight gain or sexual side effects.


How to talk to your clinician when you feel discouraged

It can be hard to advocate for yourself when you feel hopeless. Here is a script to help.

“Here’s what I tried” Script:

"Doctor, I have been taking [Medication Name] for [X] weeks. I still feel [specific symptom: unable to sleep/numb/tearful]. I am frustrated that I'm not making progress. Can we review my history and discuss if I qualify as 'treatment-resistant'? I would like to hear about options beyond just switching pills."

Questions that move the plan forward:

  • "Do I meet the criteria for NeuroStar TMS or Spravato?"

  • "Is there a biological reason (like thyroid or genes) we haven't checked?"

  • "What is a realistic timeline for this next step to work?"


What to do if symptoms worsen or safety becomes a concern

If you feel your condition is deteriorating rapidly, or if the frustration of "nothing working" leads to thoughts of giving up on life, this is an emergency.

  • Call 988 (Suicide & Crisis Lifeline).

  • Go to the nearest emergency room.

  • Do not wait for your next scheduled appointment.


How Sophroneo supports next-step planning in Atlanta

At Sophroneo Behavioral Health & TMS, we specialize in helping patients who have hit a wall with standard treatment. Serving Powder Springs, Stone Mountain, and the metro area, we offer a coordinated path for complex depression.

Coordinated evaluation and monitoring

We don't just write a prescription and wish you luck.

  • Comprehensive Review: We look at your full medication history to identify why past trials failed.

  • All Options Under One Roof: Because we offer Medication Management, Therapy, NeuroStar TMS, and Spravato, we can pivot your treatment plan without referring you out to five different clinics.

  • Insurance Navigation: We help verify if your insurance covers advanced treatments like TMS, handling the prior authorization paperwork for you.


Assumptions & Limitations

  • Not a Guarantee: While TMS and Spravato are effective for many, no medical treatment guarantees 100% remission for every patient.

  • Medical Advice: This article is for information only. Only a qualified provider can determine if you are a candidate for TRD treatments.

  • Insurance: Coverage criteria for TMS and Spravato vary by plan (e.g., how many meds you must have tried first).



Frequently Asked Questions

1. What is the success rate of TMS?

Clinical data varies, but studies on NeuroStar TMS show that many patients (often around 50–60%) experience significant improvement, and a substantial portion achieve remission (symptoms go away completely), even after medications failed.

2. Is TMS shock therapy (ECT)?

No. ECT (Electroconvulsive Therapy) uses electrical currents to induce a seizure while you are under anesthesia. TMS uses magnetic pulses to stimulate specific neurons while you are awake and alert. TMS has far fewer side effects and requires no sedation.

3. Does insurance cover TMS or Spravato?

Yes, most major insurance plans and Medicare cover NeuroStar TMS and Spravato for patients who meet the criteria for Treatment-Resistant Depression. Sophroneo can help you check your specific benefits.

4. Can I stay on my medication while doing TMS?

Yes. Many patients continue their antidepressant regimen during TMS therapy. Your clinician will guide you on the best combination strategy.

5. How do I know if I have "Treatment-Resistant Depression"?

Generally, if you have tried two or more antidepressants of adequate dose and duration without success, you may be considered treatment-resistant. A consultation with a psychiatrist is the best way to confirm this diagnosis.

6. Is Spravato the same as ketamine infusions?

Spravato (esketamine) is an FDA-approved nasal spray derived from ketamine, covered by insurance, and administered in a specific protocol. Generic ketamine infusions are often not covered by insurance and are administered intravenously. Sophroneo offers Spravato.



Comments


bottom of page